AU6979091A - Pyridinones useful as antiatherosclerotic agents - Google Patents
Pyridinones useful as antiatherosclerotic agentsInfo
- Publication number
- AU6979091A AU6979091A AU69790/91A AU6979091A AU6979091A AU 6979091 A AU6979091 A AU 6979091A AU 69790/91 A AU69790/91 A AU 69790/91A AU 6979091 A AU6979091 A AU 6979091A AU 6979091 A AU6979091 A AU 6979091A
- Authority
- AU
- Australia
- Prior art keywords
- antiatherosclerotic agents
- pyridinones
- useful
- pyridinones useful
- antiatherosclerotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45609889A | 1989-12-22 | 1989-12-22 | |
US456098 | 1995-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6979091A true AU6979091A (en) | 1991-07-24 |
Family
ID=23811414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69790/91A Abandoned AU6979091A (en) | 1989-12-22 | 1990-12-12 | Pyridinones useful as antiatherosclerotic agents |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6979091A (en) |
WO (1) | WO1991009848A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO982505L (en) * | 1997-06-04 | 1998-12-07 | Nalco Exxon Energy Chem Lp | Composition and process for desulfurization of gaseous or liquid hydrocarbons, aqueous systems and mixtures thereof |
TWI417095B (en) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
EP2004166A2 (en) * | 2006-03-31 | 2008-12-24 | La Jolla Pharmaceutical Company | Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
JP5133416B2 (en) | 2007-09-14 | 2013-01-30 | オルソー−マクニール−ジャンセン ファーマシューティカルズ, インコーポレイテッド. | 1 ', 3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H, 1'H- [1,4'] bipyridinyl-2'-one |
EP2344470B1 (en) | 2008-09-02 | 2013-11-06 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
CN102232074B (en) | 2008-11-28 | 2014-12-03 | 奥梅-杨森制药有限公司 | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
BRPI1010831A2 (en) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | 1,2,4-triazolo [4,3-a] pyridine derivatives and their as positive allosteric modulators of mglur2 receptors |
RS53075B (en) | 2009-05-12 | 2014-04-30 | Janssen Pharmaceuticals Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
AU2011328195B2 (en) | 2010-11-08 | 2015-04-02 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
PT2649069E (en) | 2010-11-08 | 2015-11-20 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
CA2815002C (en) | 2010-11-08 | 2019-10-22 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
KR20220051273A (en) | 2014-01-21 | 2022-04-26 | 얀센 파마슈티카 엔.브이. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
IL279202B2 (en) | 2014-01-21 | 2023-09-01 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
US20160002204A1 (en) * | 2014-07-03 | 2016-01-07 | Board Of Regents, The University Of Texas System | Gls1 inhibitors for treating disease |
BR112016030730B1 (en) | 2014-07-03 | 2023-05-02 | Board Of Regents, The University Of Texas System | COMPOUND |
CN107921044B (en) | 2015-06-30 | 2022-01-21 | 德州大学系统董事会 | GLS1 inhibitors for the treatment of disease |
CA3009355A1 (en) | 2015-12-22 | 2017-06-29 | Board Of Regents, The University Of Texas System | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl) acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide |
RU2020112558A (en) | 2017-10-18 | 2021-11-18 | Боард Оф Регентс, Зе Юниверсити Оф Тексас Систем | GLUTAMINASE INHIBITOR THERAPY |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2290428A1 (en) * | 1974-11-06 | 1976-06-04 | Aries Robert | Phenoxyalkyl 2-hydroxynicotinates - with antilipaemic, anorectic and hypocholesterolaemic activity |
DE2637477A1 (en) * | 1976-08-20 | 1978-02-23 | Hoechst Ag | DIHYDRO-OXO-NICOTINIC ACIDS AND METHOD FOR THE PRODUCTION THEREOF |
-
1990
- 1990-12-12 AU AU69790/91A patent/AU6979091A/en not_active Abandoned
- 1990-12-12 WO PCT/US1990/007190 patent/WO1991009848A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1991009848A1 (en) | 1991-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6979091A (en) | Pyridinones useful as antiatherosclerotic agents | |
AU655576B2 (en) | Herbicidal agents | |
AU623795B2 (en) | New substituted 1h-indazole-3-carboxamides | |
AU5748990A (en) | Venoscope | |
AU5874690A (en) | Octreotide-pamoate | |
AU6101190A (en) | Soilresisting agent | |
AU627080B2 (en) | Sulphonylaminocarbonyltriazolinones | |
AU623262B2 (en) | Hydroxypropylamines | |
AU6673290A (en) | Dipyridodiazepines | |
AU6258690A (en) | Puff-off glove | |
AU631622B2 (en) | Snow-vehicle | |
AU623780B2 (en) | Chromanderivate | |
AU5316890A (en) | Composition | |
AU5336690A (en) | Leg-guard | |
AU5782590A (en) | Thioxotetrazolines | |
AU6627590A (en) | Doll-container | |
AU6839190A (en) | Triazolylsulfonamides | |
AU5400390A (en) | Substituted 1-phenylnaphthalenes | |
AU4918390A (en) | Surfactant composition | |
AU6268590A (en) | Aminophosphinates | |
AU4944090A (en) | Cryoelectrosynthesis | |
AU6217090A (en) | Substituted amino-pyridines | |
AU623554B2 (en) | Substituted sulphonylamidinohydrazones | |
AU6627290A (en) | New construction items | |
AU5680990A (en) | Composition |